Related Experiment Video
Updated: Jun 25, 2026

08:59
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
10.7K
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis
Wenxi Wang1, Yuxiang Wang2, Wenhui Zeng1
1Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Cancer Medicine
|February 24, 2024
Summary
Prognostic factors for tongue squamous cell carcinoma (TSCC) include TNM stage and differentiation. High-quality neck lymph node dissection (LND) improves survival for early-stage TSCC patients.
Area of Science:
- Oncology
- Surgical Oncology
- Head and Neck Cancer Research
Background:
- Primary tongue squamous cell carcinoma (TSCC) is a significant head and neck malignancy.
- Accurate prognostic factor identification is crucial for treatment planning and patient outcomes.
- The role of surgical neck lymph node dissection (LND) in early-stage TSCC requires further clarification.
Purpose of the Study:
- To identify prognostic factors in surgically treated primary TSCC.
- To evaluate the benefits of surgical neck lymph node dissection (LND) for early-stage TSCC.
Main Methods:
- Retrospective analysis of 440 primary TSCC patients treated surgically (2014-2016).
- Utilized univariate and multivariate Cox models to determine prognostic factors for overall survival (OS), disease-free survival (DFS), and local recurrence-free survival (LRFS).
- Subgroup analysis assessed adjuvant therapy effects and LND prognostic value in early stages.
Main Results:
- TNM stage and pathological differentiation were independent prognostic factors for all outcomes.
- Lymphovascular invasion (LVI) and/or perineural invasion (PNI) predicted DFS.
- High-quality neck LND (≥30 nodes) significantly improved DFS and LRFS in pT1cN0M0 or Stage I TSCC patients.
Conclusions:
- TNM stage and pathological differentiation are key prognostic indicators for postoperative TSCC.
- High-quality cervical LND offers significant survival benefits for early-stage TSCC (pT1cN0M0 or Stage I).

